Skip to main content

Nasolabial Folds in Chinese Population

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Galderma
GaldermaTX - Dallas
2 programs
Restylane DefyneN/A1 trial
Restylane PerlaneN/A1 trial
Active Trials
NCT03003130Completed175Est. Sep 2018
NCT02432742Completed100Est. Aug 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GaldermaRestylane Defyne
GaldermaRestylane Perlane

Clinical Trials (2)

Total enrollment: 275 patients across 2 trials

NCT03003130GaldermaRestylane Defyne

Restylane Defyne Compared to Restylane for Correction of Moderate to Severe Nasolabial Folds

Start: Jan 2017Est. completion: Sep 2018175 patients
N/ACompleted
NCT02432742GaldermaRestylane Perlane

Efficacy and Safety of Restylane Perlane Compared to Restylane for Correction of Moderate and Severe Nasolabial Folds

Start: May 2015Est. completion: Aug 2016100 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.